{
    "eid": "2-s2.0-85065212127",
    "title": "Increased serum glypican-3 is associated with liver stiffness and hepatic dysfunction in children with biliary atresia",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Biliary atresia",
        "Glypican-3",
        "Jaundice",
        "Liver stiffness",
        "Severity"
    ],
    "authors": [
        "Kanjaporn Sirisomboonlarp",
        "Wanvisa Udomsinprasert",
        "Ellie McConachie",
        "Thamonwan Woraruthai",
        "Yong Poovorawan",
        "Sittisak Honsawek"
    ],
    "citedby-count": 5,
    "ref-count": 25,
    "ref-list": [
        "The pathogenesis of biliary atresia: Evidence for a virus-induced autoimmune disease",
        "Biliary atresia: Current concepts and research directions. Summary of a symposium",
        "Etiopathogenesis of biliary atresia",
        "Molecular mechanisms of bile duct development",
        "Dysregulation of wnt/beta-catenin signaling in gastrointestinal cancers",
        "Glypicans",
        "The loss of glypican-3 induces alterations in wnt signaling",
        "The role of glypicans in mammalian development",
        "Glypican-3: A new target for cancer immuno-therapy",
        "International incidence and outcomes of biliary atresia",
        "Interleukin 17, produced by \u03b3\u03b4 t cells, contributes to hepatic inflammation in a mouse model of biliary atresia and is increased in livers of patients",
        "Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease",
        "The correlation between plasma cytokine levels in jaundice-free children with biliary atresia",
        "Glypican-3, over-expressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling",
        "Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate",
        "Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis",
        "Down-regulating glypican-3 expression: Molecular-targeted therapy for hepatocellular carcinoma",
        "Role of glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma",
        "Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical wnt signaling",
        "Mammalian notum induces the release of glypicans and other GPI anchored proteins from the cell surface",
        "Opposing activities of dally-like glypican at high and low levels of wingless morphogen activity",
        "Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma",
        "Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma",
        "Glypican-3 immuno-cytochemistry in liver fine-needle aspirates: A novel stain to assist in the differentiation of benign and malignant liver lesions",
        "Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Science and Technology Development Agency",
        "Thailand Research Fund"
    ]
}